Global Flow Cytometry Market to Register Impressive Growth, Demand Upheld by Cancer and Stem Cell Research, Says Fact.MR – Bio-IT World

Global flow cytometry market is expected to grow at a staggering CAGR of 11.4% during the forecast period (2020-2025).

DUBLIN 2, IRELAND - Mar 23, 2020 - Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction. Moreover, flow cytometry is being increasingly used in stem-cell research where scientists examine cell conversions.

On the back of the aforementioned factors, the global flow cytometry market is set to get leveraged in the future. A staggering CAGR of 11.4% is projected for the forecast period 2020-2025, and the market is anticipated to surpass a valuation of US$ 8,119.6 Mn by the end of the forecast period.

Key Takeaways of Global Flow Cytometry Market Study

Request Sample Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=4633

The global flow cytometry market shows immense potential for future growth. The widespread application of flow cytometry in important life science disciplines such as cancer detection and stem cell research is expected to boost the global flow cytometry markets prospects in the future, concludes a Fact.MR analyst.

Acquisitions to Supplement Market Growth

The global flow cytometry market is dominated by the following players: Becton Dickinson & Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific Inc., SYSMEX CORPORATION, Alere Inc., Miltenyi Biotec, Bio-Techne, Agilent Technologies, Inc. & Bio-Rad Laboratories, Inc. Merck & Co. who constitute the maximum share of the market. The company invests in acquisitions that provide opportunities to supplement organic growth and strengthen product portfolios. Another player, Benton Dickinson and Company, offers Flow Cytometry Instruments, Software, Antibodies and Instruments. These products include BD FACSVerse, BDFACSCelesta and BD LSRFortessa. The company is a leading manufacturer and supplier of flow cytometry devices, antibodies and software.

>>> To Get more insights on flow cytometry market, visit-https://www.factmr.com/report/4633/flow-cytometry-market

About Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at Fact.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the healthcare sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Fact.MR's latestmarket research reportsand industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Fact.MR11140 Rockville PikeSuite 400Rockville, MD 20852United StatesEmail: sales@factmr.comWeb:https://www.factmr.com/

See original here:
Global Flow Cytometry Market to Register Impressive Growth, Demand Upheld by Cancer and Stem Cell Research, Says Fact.MR - Bio-IT World

Related Posts